1707 Stock Overview
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally.
Notes are coming soon
Grape King Bio Ltd Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$174.00|
|52 Week High||NT$178.00|
|52 Week Low||NT$120.00|
|1 Month Change||5.45%|
|3 Month Change||35.94%|
|1 Year Change||12.62%|
|3 Year Change||-7.45%|
|5 Year Change||-13.00%|
|Change since IPO||175.10%|
Recent News & Updates
Grape King Bio (TPE:1707) Knows How To Allocate CapitalApr 06
Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt ResponsiblyMar 22
Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You ThinkMar 06
How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?Feb 27
Grape King Bio (TPE:1707) Seems To Use Debt Quite SensiblyNov 20
|1707||TW Personal Products||TW Market|
Return vs Industry: 1707 matched the TW Personal Products industry which returned 13.5% over the past year.
Return vs Market: 1707 exceeded the TW Market which returned -11.6% over the past year.
|1707 Average Weekly Movement||3.9%|
|Personal Products Industry Average Movement||5.8%|
|Market Average Movement||4.0%|
|10% most volatile stocks in TW Market||7.2%|
|10% least volatile stocks in TW Market||1.8%|
Stable Share Price: 1707 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 1707's weekly volatility (4%) has been stable over the past year.
About the Company
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes.
Grape King Bio Ltd Fundamentals Summary
|1707 fundamental statistics|
Is 1707 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|1707 income statement (TTM)|
|Cost of Revenue||NT$1.90b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||9.62|
|Net Profit Margin||14.00%|
How did 1707 perform over the long term?See historical performance and comparison